Palo Alto, CA– One of the most sizable issues with present-day data tracking is that we have every imaginable way of tracking our personal data, but we haven’t figured out a way to make that data improve our lives. Glooko is tackling the “so what” in the health tracking movement and taking steps towards actionable data for diabetics.

The new app, Glooko, syncs blood glucose meter data to your mobile device (iOS or Android) and brings that data to life. The app is able to log dietary habits, insulin levels, and physical activity. And since physical activity is such a common trigger for drastic drops in blood sugar, diabetics that track their physical activity are able to view how it affects their levels and make informed adjustments as needed.

Not only is the data that is collected from Glooko’s app beneficial to adding a new level of insight into a diabetic’s personal lifestyle decisions, but it can be helpful for their healthcare providers as well. Sharing this data with healthcare providers can improve the provider-patient communication and help drive a more personalized and workable diabetes management plan. Glooko is a perfect tool for diabetic patients that may be considered high-risk, but can also serve the practical needs of average patients

https://www.youtube.com/watch?v=bREiKZI0H-A

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.